James E Besser has an estimated net worth of $3.84 Billion. This is based on reported shares across multiple companies, which include CIPHERLOC Corp, Medifirst Solutions, Inc., Modular Medical, Inc., FENNEC PHARMACEUTICALS INC., NEUROONE MEDICAL TECHNOLOGIES Corp, Processa Pharmaceuticals, Inc., Zoom Telephonics, Inc., BRAIN SCIENTIFIC INC., SANUWAVE Health, Inc., and NTS, INC..
2016 was James E Besser's most active year for acquiring shares with 58 total transactions. James E Besser's most active month to acquire stocks was the month of November. 2024 was James E Besser's most active year for disposing of shares, totalling 32 transactions. James E Besser's most active month to dispose stocks was the month of September. 2024 saw James E Besser paying a total of $15,640,783.73 for 11,997,852 shares, this is the most they've acquired in one year. In 2020 James E Besser cashed out on 7,431,071 shares for a total of $14,490,588.45, their largest year based on trade value.